The authors revealed that ASCL1 was regulated by the SRY-box transcription factor 2 and highly expressed in neuroendocrine prostate cancer cells, which was closely related to poor prognosis.
[Free Radical Biology and Medicine]
ASCL1-Mediated Ferroptosis Resistance Enhances the Progress of Castration-Resistant Prostate Cancer to Neurosecretory Prostate Cancer
